TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00736905
Recruitment Status : Completed
First Posted : August 18, 2008
Last Update Posted : April 28, 2010
Information provided by:
Tibotec Pharmaceuticals, Ireland

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2009
  Study Completion Date : November 2009